CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

ProbioticWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)

Name (Synonyms) Correlation
drug68 Assessment of cardiovascular diseases and cardiovascular risk factors Wiki 1.00
drug220 Control Wiki 0.50

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D002318 Cardiovascular Diseases NIH 0.30

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Multicentric Study to Assess the Effect of Consumption of Lactobacillus Coryniformis K8 on Healthcare Personnel Exposed to COVID-19

The aim of the present study is to evaluate the effects of Lactobacillus coryniformis K8 consumption on the incidence and severity of Covid-19 in health workers exposed to the virus. This is a preventive study

NCT04366180 Covid-19 Dietary Supplement: Probiotic Dietary Supplement: Control

Primary Outcomes

Description: The incidence of SARS CoV-2 infection will be confirmed by PCR or antigen test

Measure: Incidence of SARS CoV-2 infection in healthcare workers

Time: 8 weeks

Secondary Outcomes

Description: In the healthcare workers that confirm the SARS Cov-2 infection (primary variable), it will be evaluated how many of them will required hospital admission because of Covid-19

Measure: Incidence of hospital admissions caused by SARS-CoV-2 infection

Time: 8 weeks

Description: In the healthcare workers that confirm the SARS Cov-2 infection (primary variable), it will be evaluated how many of them will required ICU admission because of Covid-19

Measure: Incidence of ICU admissions caused by SARS-CoV-2 infection

Time: 8 weeks

Description: In the healthcare workers that confirm the SARS Cov-2 infection (primary variable), it will be evaluated how many of them will develop pneumonia because of Covid-19

Measure: Incidence of pneumonia caused by SARS-CoV-2 infection

Time: 8 weeks

Description: In the healthcare workers that confirm the SARS Cov-2 infection (primary variable), it will be evaluated how many of them will require oxygen support because of Covid-19

Measure: Incidence of oxygen support requirement caused by SARS-CoV-2 infection

Time: 8 weeks

Description: In the healthcare workers that confirm the SARS Cov-2 infection (primary variable), it will be evaluated how many of them will develop gastrointestinal symptoms because of Covid-19

Measure: Incidence of gastrointestinal symptoms caused by SARS-CoV-2 infection

Time: 8 weeks

Description: In the healthcare workers that confirm the SARS Cov-2 infection (primary variable), number of days with body's temperature > 37.5 ºC during the course of the disease

Measure: Days with body's temperature > 37.5 ºC

Time: 8 weeks

Description: In the healthcare workers that confirm the SARS Cov-2 infection (primary variable), number of days with cough during the course of the disease

Measure: Days with cough

Time: 8 weeks

Description: In the healthcare workers that confirm the SARS Cov-2 infection (primary variable), number of days with fatigue during the course of the disease

Measure: Days with fatigue

Time: 8 weeks

Description: Use of drugs (dosis and duration of the treatment) for Covid-19 treatment

Measure: Medical treatment

Time: 8 weeks

No related HPO nodes (Using clinical trials)